Addition of a “simple” clinical risk score on top of current risk assessment tools may improve identification of patients undergoing chemotherapy likely to develop treatment-related cardiotoxicity, researchers reported.
The use of the novel RE-ACT score on top of the Heart Failure Association-International Cardio-Oncology Society (HFA-ICOS) score improved the discrimination of either tool when used alone, according to data published in JACC: CardioOncology.
“Several risk factors for anthracycline-induced cardiotoxicity have been identified, including advanced age, preexisting

The oral GLP-1 orforglipron was noninferior to insulin glargine for major adverse cardiovascular events in patients with type 2 diabetes at high CV risk, according to results of the ACHIEVE-4 trial.
For ACHIEVE-4, presented at the European Association for the Study of Diabetes Annual Meeting and simultaneously published in The Lancet, researchers randomly assigned 2,749 patients (mean age, 63 years; 38% women) with type 2 diabetes (mean HbA1c, 8.2%), overweight or obesity (BMI 25 kg/m2; mean, 33 kg/m2) and established cardiovascular disease or chronic kidney disease to orforglipron (Foundayo,

Manila doctors traced a rice farmer's brief shaking spell to brain schistosomiasis after the Philippines' 2025 goal to stop the parasite passed.

After two falls, a 77-year-old's scan looked like a brain bleed. Surgery revealed a rare follicular lymphoma growing in the brain's lining.

Labs and CT couldn't tell doctors what sat by a man's adrenal gland, so surgery became the test. It was a rare airway cyst below the diaphragm.

A 13-mm lump on a woman's first screening mammogram turned out to be working thyroid tissue, a finding seen only in isolated case reports.

CDC data show 72,093 violent deaths in 2023, with suicide making up 62% and firearms involved in 58.6%. Call or text 988 for help 24/7.

$500 HealthCare.gov refunds started arriving Sept. 30 with a Trump letter. Here's who qualifies, how payments arrive, and how to avoid copycat scams.

Survodutide cut weight by up to 13.1% in adults with type 2 diabetes in a company-funded trial. It is not approved, and 18% quit due to side effects.

CMS finalized GLOBE, tying some Medicare Part B drug rebates to prices abroad. Here's who is included, when costs drop, and what changed.